The IL-1β-mediated induction of PGE2 secretion from MSCs leads to β-catenin activation and the induction of malignant transformation of HSCs, up-regulation of ARC, and enhanced chemotherapy resistance in AML [141]. This evidence concerns the gene IL1B and acute myeloid leukemia.